Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Biosense celebrates the University’s leading science research by combining scientific stories with incredible images and previously unseen museum specimens.

Fluorescent labelled cones © Steven Hughes
Fluorescent labelled cones
This is the first exhibition in the Museum’s ambitious new Contemporary Science & Society series that will look at current multi-disciplinary research into organisms and the natural environment, all within the splendour of the Museum’s Victorian building.
- Professor Paul Smith, director of the Museum of Natural History

The exhibition features the research of Stuart Peirson in our Department. He will be giving a 20-minute talk on 16 May at 2.00pm and again on 6 June at 2.00pm, explaining photoreceptors and circadian rhythms and how light regulates physiology and behaviour.

Accompanying the exhibition will be a Biosense trail to encourage visitors to discover other specimens in the displays that are relevant to the show. 

On 4 June there will be a symposium, with talks from the researchers whose work features in the exhibition.

Biosense runs 8 May to 24 August 2015. The full Museum programme is available on the website.

Similar stories

Celebrating International Women's Day

100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution.

Scientists uncover the role of neuronal networks in moving between wake and sleep states

Changes in the way that neurons communicate with each other affect our ability to move between sleep and wake states.

Professor Robert MacLaren receives Innovation Award

Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.